Literature DB >> 18525132

The pathology of "vascular dementia": a critical update.

Kurt A Jellinger1.   

Abstract

The prevalence, morphology and pathogenesis of vascular dementia (VaD), recently termed vascular cognitive disorder (VCD), are a matter of discussion.VaD is suggested in 8-15% of cognitively impaired aged subjects. Its prevalence in autopsy series ranges from 0.03 to 58% (mean 8-15% in Western series, 22-35% in Japan). Neuropathology shows multifocal and/or diffuse lesions, ranging from lacunes and microinfarcts, often involving subcortical and strategically important brain areas (thalamus, frontobasal, limbic system), white matter lesions and hippocampal sclerosis to multi-infarct encephalopathy and diffuse post-ischemic lesions. They result from systemic, cardiac and local large and small vessel disease. Pathogenesis is multifactorial and pathophysiology affects neuronal networks involved in cognition, behavior, execution and memory. Vascular lesions often coexist with Alzheimer's disease (AD) and other pathologies. Minor vascular lesions hardly contribute to cognitive decline in full-blown AD, while both mild Alzheimer pathology and small vessel disease interact synergistically. AD pathology is less severe in the presence of vascular lesions. The lesion pattern in "pure" VaD/VCD) related to microangiopathies differs from that in "mixed dementia" (AD + vascular encephalopathy), often associated with large infarcts, suggesting different pathogenesis. Due to the heterogeneity of cerebrovascular pathology and its causative factors, no validated neuropathologic criteria for VaD are currently available, and a large variability across laboratories still exists in morphologic examination procedures and techniques. Further prospective clinico-pathologic studies are needed to validate diagnostic criteria for VaD and to clarify the impact of vascular lesions on cognitive impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18525132     DOI: 10.3233/jad-2008-14110

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  52 in total

Review 1.  Neuropathology in the adult changes in thought study: a review.

Authors:  Joshua A Sonnen; Eric B Larson; Sebastien Haneuse; Randy Woltjer; Ge Li; Paul K Crane; Suzanne Craft; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 2.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

Review 3.  Don't forget astrocytes when targeting Alzheimer's disease.

Authors:  Jessica S Sadick; Shane A Liddelow
Journal:  Br J Pharmacol       Date:  2019-02-19       Impact factor: 8.739

Review 4.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

5.  The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.

Authors:  Samantha E John; Ashita S Gurnani; Cara Bussell; Jessica L Saurman; Jason W Griffin; Brandon E Gavett
Journal:  Neuropsychology       Date:  2016-11       Impact factor: 3.295

Review 6.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

7.  Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

Authors:  C Messier; M Gagnon
Journal:  Diabetologia       Date:  2009-09-25       Impact factor: 10.122

Review 8.  Global expression profiling in epileptogenesis: does it add to the confusion?

Authors:  Yi Yuen Wang; Paul Smith; Michael Murphy; Mark Cook
Journal:  Brain Pathol       Date:  2009-02-24       Impact factor: 6.508

9.  Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model.

Authors:  Csaba Nyakas; Klára Felszeghy; Róbert Szabó; Jan N Keijser; Paul G M Luiten; Zsolt Szombathelyi; Károly Tihanyi
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

Review 10.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.